Clinical Trial

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

Name: Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome — clinical trial record (NCT07702981)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed

View on ClinicalTrials.gov →

Summary

Immunophenotyping profiling of patients with primary MN, primary FSGS and MCD. Evaluation of these immune cell subsets as possible biomarkers to track response to treatment or disease relapse.

Trial Details

NCT Number	NCT07702981
Lead Sponsor	University Hospital, Ioannina
Conditions	Membranous Nephropathy, Minimal Change Disease (MCD), Focal Segmental Glomerulosclerosis (FSGS)
Enrollment	40 participants
Start Date	2023-06-01
Primary Completion	2025-11-01 (estimated)
Study Completion	2026-02-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-14